Apothékary
PrivateLast Round
Series A
Extension
Jun 29, 2026
Total Funding Raised
$38M
Company Overview
Apothékary operates in Consumer & Commerce and is based in Falls Church, Virginia. Its latest recorded funding round was a Series A Extension round in June 2026.
Apothékary is a wellness company that provides Japanese-inspired plant-based herbal tinctures and supplements as alternatives to over-the-counter drugs and synthetic supplements.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Subscription Commerce, Fashion & Beauty
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apothékary Comparables
Compare Apothékary with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Moon Juice | 87% | |
| Golde | 87% | |
| Four Sigmatic | 84% |
For institutional investors. Book with your work email.
Apothékary Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 29, 2026 | ||||
| Series A | Nov 20, 2024 | ||||
| Debt | Mar 14, 2024 | ||||
| Seed | Sep 1, 2022 | ||||
| Seed | Nov 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Apothékary Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RSF Social Finance | Series A Extension |
| Shiseido | Series A Extension, Series A |
| Trousdale Ventures | Series A, Seed |
| Venrex Investment Management | Series A, Seed |
| Stella Capital | Series A |
| NextLevel Management | Series A Extension |
| Strand Equity | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Founder Shizu Okusa received the Inc. 500 Female Founder Honoree award.
- Jan 1, 2026
Introduced a 30-day guided program called the 'Break the Stress Cycle Challenge'.
For institutional investors. Book with your work email.
Apothékary Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Apothékary's valuation, stock price, and market status.
Is Apothékary a public or private company?
Apothékary is a private company.
What is the current stock price of Apothékary?
Apothékary is a private company, so its shares have no public market price. Caplight tracks Apothékary's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Apothékary worth (valuation)?
Valuation information for Apothékary is not publicly available.
Can I buy Apothékary stock?
Apothékary shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Apothékary's last funding round?
Apothékary's most recent funding round was Series A Extension on June 29, 2026.
Who are the main investors in Apothékary?
Key investors in Apothékary include Shiseido.
Will Apothékary IPO soon?
No public IPO plans have been announced for Apothékary.
How can I track Apothékary secondary market activity?
Caplight tracks bids, offers, and trades in Apothékary's shares on secondary markets.